Government to opt for EP regulations over biosimilar products

Published: 2008-10-09 07:00:00
Updated: 2008-10-09 07:00:00
The Korea Food and Drug Administration is considering adopting the European regulations and guidelines in the process of screening biosimilar products.

The health regulator says the EP regulations are less stringent than those in the United States in order to boost the domestic pharmaceutical ...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.